228 related articles for article (PubMed ID: 20949975)
1. Diverse effects on the native β-sheet of the human prion protein due to disease-associated mutations.
Chen W; van der Kamp MW; Daggett V
Biochemistry; 2010 Nov; 49(45):9874-81. PubMed ID: 20949975
[TBL] [Abstract][Full Text] [Related]
2. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
[TBL] [Abstract][Full Text] [Related]
3. Mutation-Dependent Refolding of Prion Protein Unveils Amyloidogenic-Related Structural Ramifications: Insights from Molecular Dynamics Simulations.
Palaniappan C; Narayanan RC; Sekar K
ACS Chem Neurosci; 2021 Aug; 12(15):2810-2819. PubMed ID: 34296847
[TBL] [Abstract][Full Text] [Related]
4. Generating Bona Fide Mammalian Prions with Internal Deletions.
Munoz-Montesino C; Sizun C; Moudjou M; Herzog L; Reine F; Chapuis J; Ciric D; Igel-Egalon A; Laude H; Béringue V; Rezaei H; Dron M
J Virol; 2016 Aug; 90(15):6963-6975. PubMed ID: 27226369
[TBL] [Abstract][Full Text] [Related]
5. The H187R mutation of the human prion protein induces conversion of recombinant prion protein to the PrP(Sc)-like form.
Hosszu LL; Tattum MH; Jones S; Trevitt CR; Wells MA; Waltho JP; Collinge J; Jackson GS; Clarke AR
Biochemistry; 2010 Oct; 49(40):8729-38. PubMed ID: 20718410
[TBL] [Abstract][Full Text] [Related]
6. Influence of the pathogenic mutations T188K/R/A on the structural stability and misfolding of human prion protein: insight from molecular dynamics simulations.
Guo J; Ning L; Ren H; Liu H; Yao X
Biochim Biophys Acta; 2012 Feb; 1820(2):116-23. PubMed ID: 22155634
[TBL] [Abstract][Full Text] [Related]
7. Exploring the propensities of helices in PrP(C) to form beta sheet using NMR structures and sequence alignments.
Dima RI; Thirumalai D
Biophys J; 2002 Sep; 83(3):1268-80. PubMed ID: 12202354
[TBL] [Abstract][Full Text] [Related]
8. Common structural traits across pathogenic mutants of the human prion protein and their implications for familial prion diseases.
Rossetti G; Cong X; Caliandro R; Legname G; Carloni P
J Mol Biol; 2011 Aug; 411(3):700-12. PubMed ID: 21689662
[TBL] [Abstract][Full Text] [Related]
9. Structural instability of the prion protein upon M205S/R mutations revealed by molecular dynamics simulations.
Hirschberger T; Stork M; Schropp B; Winklhofer KF; Tatzelt J; Tavan P
Biophys J; 2006 Jun; 90(11):3908-18. PubMed ID: 16513786
[TBL] [Abstract][Full Text] [Related]
10. Preventing misfolding of the prion protein by trimethylamine N-oxide.
Bennion BJ; DeMarco ML; Daggett V
Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
[TBL] [Abstract][Full Text] [Related]
11. Temperature-Induced Misfolding in Prion Protein: Evidence of Multiple Partially Disordered States Stabilized by Non-Native Hydrogen Bonds.
Chamachi NG; Chakrabarty S
Biochemistry; 2017 Feb; 56(6):833-844. PubMed ID: 28102071
[TBL] [Abstract][Full Text] [Related]
12. Prions.
Colby DW; Prusiner SB
Cold Spring Harb Perspect Biol; 2011 Jan; 3(1):a006833. PubMed ID: 21421910
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the PrPc Amino-Terminal Domain in Prion Species Barriers.
Davenport KA; Henderson DM; Mathiason CK; Hoover EA
J Virol; 2016 Dec; 90(23):10752-10761. PubMed ID: 27654299
[TBL] [Abstract][Full Text] [Related]
14. Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure.
Cobb NJ; Sönnichsen FD; McHaourab H; Surewicz WK
Proc Natl Acad Sci U S A; 2007 Nov; 104(48):18946-51. PubMed ID: 18025469
[TBL] [Abstract][Full Text] [Related]
15. Structural effects of the highly protective V127 polymorphism on human prion protein.
Hosszu LLP; Conners R; Sangar D; Batchelor M; Sawyer EB; Fisher S; Cliff MJ; Hounslow AM; McAuley K; Leo Brady R; Jackson GS; Bieschke J; Waltho JP; Collinge J
Commun Biol; 2020 Jul; 3(1):402. PubMed ID: 32728168
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in the histo-molecular pathology of human prion disease.
Baiardi S; Rossi M; Capellari S; Parchi P
Brain Pathol; 2019 Mar; 29(2):278-300. PubMed ID: 30588685
[TBL] [Abstract][Full Text] [Related]
17. Residue-specific mobility changes in soluble oligomers of the prion protein define regions involved in aggregation.
Glaves JP; Ladner-Keay CL; Bjorndahl TC; Wishart DS; Sykes BD
Biochim Biophys Acta Proteins Proteom; 2018 Sep; 1866(9):982-988. PubMed ID: 29935976
[TBL] [Abstract][Full Text] [Related]
18. A transmembrane form of the prion protein in neurodegenerative disease.
Hegde RS; Mastrianni JA; Scott MR; DeFea KA; Tremblay P; Torchia M; DeArmond SJ; Prusiner SB; Lingappa VR
Science; 1998 Feb; 279(5352):827-34. PubMed ID: 9452375
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity and Architecture of Pathological Prion Protein Assemblies: Time to Revisit the Molecular Basis of the Prion Replication Process?
Igel-Egalon A; Bohl J; Moudjou M; Herzog L; Reine F; Rezaei H; Béringue V
Viruses; 2019 May; 11(5):. PubMed ID: 31083283
[TBL] [Abstract][Full Text] [Related]
20. β-hairpin-mediated formation of structurally distinct multimers of neurotoxic prion peptides.
Gill AC
PLoS One; 2014; 9(1):e87354. PubMed ID: 24498083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
